CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹169 Cr | ₹184 Cr | ₹142 Cr | ₹192 Cr | ₹344 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹169 Cr |
| Mar2025 | ₹184 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹344 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹169 Cr | -8.14 | |
| Mar2025 | ₹184 Cr | 29.48 | |
| Mar2024 | ₹142 Cr | -25.90 | |
| Mar2023 | ₹192 Cr | -44.27 | |
| Mar2022 | ₹344 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,305.1 Cr | -3.2% | 4.8% | -22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -3.2% |
4.8% |
-22.3% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses